★ Retirer favori
Fiche traitement

Gabapentin

Tanta University • SEP

Suivi actif Non applicable

Résumé

Gabapentin est développé par Tanta University. Le traitement est actuellement en Non applicable. Il est associé à SEP. Son objectif thérapeutique principal est À vérifier. Le statut actuel est : suivi actif.

À vérifier

À vérifier
Non applicable
Tanta University
Egypt
The aim of this study is to compare the safety and efficacy of theophylline, sumatriptan, and gabapentin in the treatment of post-dural puncture headache.
2026-03-31

Début phase actuelle
Non disponible dans les sources synchronisées
Timeline clinique

Non applicable
Préclinique
Phase 1
Phase 2
Phase 3
Approuvé

Objectif scientifique de l’étude

classification automatique vérifiable
À vérifier Confiance automatique : 0%
Contrôle de cohérence : 85/100

L’objectif est absent ou classé « Autre » et doit être recalculé à partir du protocole.

Transparence et qualité de la fiche

données vérifiables
ClassificationÀ vérifier
Confiance de la fiche85 %
Source principaleSource officielle ou publication indexée
Dernière vérification2026-03-31
Anomalies détectées1
Validation humaineValidation humaine non effectuée
Donnée issue d’une source Donnée normalisée automatiquement Interprétation algorithmique

Classification scientifique multi-axes

ne pas confondre statut et résultat
État de l’étudeStatut inconnu
Disponibilité des résultatsRésultats à vérifier
InterprétationImpossible à déterminer
Niveau de preuveNon évaluable

Un essai terminé n’est pas nécessairement positif. Un essai arrêté n’est classé comme échec scientifique que lorsqu’un résultat ou une raison explicite le confirme.

Indicateurs factuels

sans score subjectif
Phase enregistréeNon applicable
Études associées1
Publications associées20
Statut consolidéSuivi actif

Aucune chance de succès, note d’innovation, potentiel thérapeutique ou probabilité de commercialisation n’est calculé tant qu’un modèle validé et des données suffisantes ne sont pas disponibles.

Historique factuel de la molécule

24 événement(s) daté(s)

Cette liste reprend uniquement les dates trouvées dans les registres et publications liés. Elle ne constitue pas une prévision.

DateÉvénementSource
2024-12-01Début de l’étudeNCT07515456Registre d’essai clinique
2026-03-31Dernière mise à jour des donnéesGabapentinBiomedical Watch
2026-07-08PublicationLong-Term Inhaled Cannabis Therapy for Chronic Low Back Pain: A Five-Year Retrospective Analysis of Prospectively Collected Patient-Reported Outcomes in 241 Treatment-Refractory Patients.Biomedicines
2026-07-08PublicationIncidence and clinical characteristics of taxane-induced peripheral neuropathy requiring treatment in patients with breast cancer.Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
2026-07-08PublicationAnti-seizure medication in Germany over 25 years: trends in prices and prescription patterns from national data from 2000 to 2024.Epilepsy & behavior : E&B
2026-07-08PublicationPilot RCT comparing low-dose naltrexone, gabapentin and placebo to reduce pain among people with HIV with alcohol problems.PloS one
2026-07-12PublicationPerioperative Pregabalin for Recurrent Intractable Hiccups: A Case Report and Literature Review.Case reports in anesthesiology
2026-07-14PublicationManagement of Pain and Pruritus in Pediatric Recessive Dystrophic Epidermolysis Bullosa.Clinical case reports
2026-07-14PublicationAcute trazodone administration reduces behavioral and physiological indicators of travel-induced anxiety in dogs in a road travel model.Frontiers in veterinary science
2026-07-18PublicationFacial solitary morphea profunda presenting with painful trigeminal neuropathy: A case report.Cephalalgia : an international journal of headache
2026-07-23PublicationOnce-Nightly Pregabalin for Co-Occurring Nightmares, Poor Sleep, and Headaches: A Case Series.Nature and science of sleep
2026-08-13PublicationLeveraging Signal Detection and Mendelian Randomization in Spontaneous Reporting for Post-Marketing Surveillance of Drug- Induced Amnesia.Current medicinal chemistry
2026-08-13PublicationComparative Effectiveness, Safety, and Costs of Gabapentinoids in Older Adults With Long-Term Opioid Use.Journal of the American Geriatrics Society
2026-08-16PublicationAdvances in ERAS to Reduce the Incidence of Chronic Post-Surgical Pain and Persistent Postoperative Opioid Use: A Narrative Review.Journal of investigative surgery : the official journal of the Academy of Surgical Research
2026-08-16PublicationVoltage-gated sodium channels in the nervous system: Molecular physiology to therapeutic interventions.Neural regeneration research
2026-08-16PublicationPotassium Channelopathies and Precision Medicine Approaches in Epilepsy: A Systematic Review of Personalized Treatment Strategies.Current neuropharmacology
2026-08-16PublicationDownbeat nystagmus: a practical approach based on a clinical case.Arquivos de neuro-psiquiatria
2026-08-16PublicationLocal therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.The Journal of dermatological treatment
2026-08-16PublicationPharmacologic management of postoperative sleep disturbance in breast cancer.Frontiers in pharmacology
2026-08-16PublicationPrescribing Patterns of Gabapentinoids in Patients with Chronic Obstructive Pulmonary Disorder.COPD
2026-08-16PublicationGabapentinoids and unexplained death in general practice: Case series and feasibility study arising from a critical incident.The European journal of general practice
2026-08-16PublicationAssociation Between the Use of Gabapentinoids and Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis.Current therapeutic research, clinical and experimental
2026-11-01Fin de l’étude prévue / enregistréeNCT07515456Registre d’essai clinique
2026-11-22Création de l’enregistrementNCT07515456Registre d’essai clinique

Début phase actuelle
Non disponible dans les sources synchronisées
Essais cliniques liés

1 essai(s)
NCT Titre Phase Statut administratif Pays Sponsor
NCT07515456 Theophylline, Versus Sumatriptan and Gabapentin in The Treatment of Post-Dural Puncture Headache Non applicable RECRUITING Egypt Tanta University

Publications liées

20 publication(s)

Publications liées

20 publication(s)
Titre PMID DOI Journal Date
Advances in ERAS to Reduce the Incidence of Chronic Post-Surgical Pain and Persistent Postoperative Opioid Use: A Narrative Review. Voir source 42138101 10.1080/08941939.2026.2664932 Journal of investigative surgery : the official journal of the Academy of Surgical Research
Voltage-gated sodium channels in the nervous system: Molecular physiology to therapeutic interventions. Voir source 40808385 10.4103/NRR.NRR-D-25-00260 Neural regeneration research
Potassium Channelopathies and Precision Medicine Approaches in Epilepsy: A Systematic Review of Personalized Treatment Strategies. Voir source 42003125 10.2174/011570159X407197251204124232 Current neuropharmacology
Downbeat nystagmus: a practical approach based on a clinical case. Voir source 42594882 10.1055/s-0046-1827165 Arquivos de neuro-psiquiatria
Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids. Voir source 41884965 10.1080/09546634.2026.2646556 The Journal of dermatological treatment
Pharmacologic management of postoperative sleep disturbance in breast cancer. Voir source 42591116 10.3389/fphar.2026.1844297 Frontiers in pharmacology
Prescribing Patterns of Gabapentinoids in Patients with Chronic Obstructive Pulmonary Disorder. Voir source 41510798 10.1080/15412555.2025.2596683 COPD
Gabapentinoids and unexplained death in general practice: Case series and feasibility study arising from a critical incident. Voir source 41871002 10.1080/13814788.2026.2645473 The European journal of general practice
Association Between the Use of Gabapentinoids and Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis. Voir source 42405224 10.1016/j.curtheres.2026.100836 Current therapeutic research, clinical and experimental
Leveraging Signal Detection and Mendelian Randomization in Spontaneous Reporting for Post-Marketing Surveillance of Drug- Induced Amnesia. Voir source 41941166 10.2174/0109298673377176251207133923 Current medicinal chemistry
Comparative Effectiveness, Safety, and Costs of Gabapentinoids in Older Adults With Long-Term Opioid Use. Voir source 42576615 10.1111/jgs.70633 Journal of the American Geriatrics Society
Once-Nightly Pregabalin for Co-Occurring Nightmares, Poor Sleep, and Headaches: A Case Series. Voir source 42483729 10.2147/NSS.S600495 Nature and science of sleep
Facial solitary morphea profunda presenting with painful trigeminal neuropathy: A case report. Voir source 30213201 10.1177/0333102418801580 Cephalalgia : an international journal of headache
Management of Pain and Pruritus in Pediatric Recessive Dystrophic Epidermolysis Bullosa. Voir source 42437100 10.1002/ccr3.73135 Clinical case reports
Acute trazodone administration reduces behavioral and physiological indicators of travel-induced anxiety in dogs in a road travel model. Voir source 42441254 10.3389/fvets.2026.1851849 Frontiers in veterinary science
Perioperative Pregabalin for Recurrent Intractable Hiccups: A Case Report and Literature Review. Voir source 42436812 10.1155/cria/6329954 Case reports in anesthesiology
Long-Term Inhaled Cannabis Therapy for Chronic Low Back Pain: A Five-Year Retrospective Analysis of Prospectively Collected Patient-Reported Outcomes in 241 Treatment-Refractory Patients. Voir source 42351683 10.3390/biomedicines14061255 Biomedicines
Incidence and clinical characteristics of taxane-induced peripheral neuropathy requiring treatment in patients with breast cancer. Voir source 42417003 10.1177/10781552261469836 Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Anti-seizure medication in Germany over 25 years: trends in prices and prescription patterns from national data from 2000 to 2024. Voir source 42398365 10.1016/j.yebeh.2026.111174 Epilepsy & behavior : E&B
Pilot RCT comparing low-dose naltrexone, gabapentin and placebo to reduce pain among people with HIV with alcohol problems. Voir source 38408060 10.1371/journal.pone.0297948 PloS one

Sources officielles

liens de recherche

Dernière mise à jour des données : 2026-03-31

Ces sources sont proposées pour vérification. Les informations de la fiche doivent être confirmées dans les registres officiels ou les publications originales.